Invention Grant
- Patent Title: Soft gelatin capsule formulation
-
Application No.: US16351659Application Date: 2019-03-13
-
Publication No.: US10774091B2Publication Date: 2020-09-15
- Inventor: Mike Trower , Monica Lazaro , Derek Bush , David Elder , Mary Kerr
- Applicant: KaNDy Therapeutics Limited
- Applicant Address: GB Stevenage Herts
- Assignee: KaNDy Therapeutics Limited
- Current Assignee: KaNDy Therapeutics Limited
- Current Assignee Address: GB Stevenage Herts
- Agency: Silvia Salvadori, P.C.
- Agent Silvia Salvadori
- Main IPC: C07D498/04
- IPC: C07D498/04 ; A61P15/00 ; A61K31/5383

Abstract:
The present invention generally relates to novel pharmaceutical formulations containing 2-[3,5-Bis(trifluoromethyl)phenyl]-N-{4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-3-pyridinyl}-N,2-dimethylpropanamide, methods of preparation thereof and their use in medical therapy.
Public/Granted literature
- US20190284205A1 NOVEL PHARMACEUTICAL FORMULATION Public/Granted day:2019-09-19
Information query